Diagnostic significance of reassessment of prostate biopsy specimens by experienced urological pathologists at a high-volume institution

In prostate cancer, accurate diagnosis and grade group (GG) decision based on biopsy findings are essential for determining treatment strategies. Diagnosis by experienced urological pathologists is recommended; however, their contribution to patient benefits remains unknown. Therefore, we analyzed c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Virchows Archiv : an international journal of pathology 2022-05, Vol.480 (5), p.979-987
Hauptverfasser: Okubo, Yoichiro, Yamamoto, Yayoi, Sato, Shinya, Yoshioka, Emi, Suzuki, Masaki, Washimi, Kota, Osaka, Kimito, Suzuki, Takahisa, Yokose, Tomoyuki, Kishida, Takeshi, Miyagi, Yohei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 987
container_issue 5
container_start_page 979
container_title Virchows Archiv : an international journal of pathology
container_volume 480
creator Okubo, Yoichiro
Yamamoto, Yayoi
Sato, Shinya
Yoshioka, Emi
Suzuki, Masaki
Washimi, Kota
Osaka, Kimito
Suzuki, Takahisa
Yokose, Tomoyuki
Kishida, Takeshi
Miyagi, Yohei
description In prostate cancer, accurate diagnosis and grade group (GG) decision based on biopsy findings are essential for determining treatment strategies. Diagnosis by experienced urological pathologists is recommended; however, their contribution to patient benefits remains unknown. Therefore, we analyzed clinicopathological information to determine the significance of reassessment by experienced urological pathologists at a high-volume institution to identify factors involved in the agreement or disagreement of biopsy and surgical GGs. In total, 1325 prostate adenocarcinomas were analyzed, and the GG was changed in 452/1325 (34.1%) cases (359 cases were upgraded, and 93 cases were downgraded). We compared the highest GG based on biopsy specimens, with the final GG based on surgical specimens of 210 cases. The agreement rate between the surgical GG performed and assessed in our institute and the highest biopsy GG assessed by an outside pathologist was 34.8% (73/210); the agreement rate increased significantly to 50% (105/210) when biopsy specimens were reevaluated in our institute (chi-square test, P  
doi_str_mv 10.1007/s00428-022-03272-0
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9033711</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2653413660</sourcerecordid><originalsourceid>FETCH-LOGICAL-c540t-d5f6256c5fe1cd5acd9c29cd2f39f5a12676da802b30af11f4c115563c60fab63</originalsourceid><addsrcrecordid>eNp9kc2OFCEUhYnROO3oC7gwJG7clHKhoLo2Jmb8TSZxo2tCUVDNpBpKLjWx38DHlp4ex5-FG8jN-e65XA4hT4G9BMa6V8hYy7cN47xhgnf1vEc20ArecMG6-2TD-lY2SkB3Rh4hXjHGYQvqITkTkoEEwTbkx9tgppiwBEsxTDH4YE20jiZPszOIDnHvYjnWS66cKY4OIS14oLg4G6qIdDhQ931xObjaOtI1pzlN1Wimiym7mwILUlOoobsw7ZrrNK97R0Osg8taQoqPyQNvZnRPbu9z8vX9uy8XH5vLzx8-Xby5bKxsWWlG6RWXykrvwI7S2LG3vLcj96L30gBXnRrNlvFBMOMBfGsBpFTCKubNoMQ5eX3yXdZh70Zbd8tm1ksOe5MPOpmg_1Zi2OkpXeueCdEBVIMXtwY5fVsdFr0PaN08m-jSipor2PYg-1ZU9Pk_6FVac6zrVUqKFoRSrFL8RNn6v5idv3sMMH0MWp-C1jVofRO0PjY9-3ONu5ZfyVZAnACsUpxc_j37P7Y_AaVFuFs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2653413660</pqid></control><display><type>article</type><title>Diagnostic significance of reassessment of prostate biopsy specimens by experienced urological pathologists at a high-volume institution</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Okubo, Yoichiro ; Yamamoto, Yayoi ; Sato, Shinya ; Yoshioka, Emi ; Suzuki, Masaki ; Washimi, Kota ; Osaka, Kimito ; Suzuki, Takahisa ; Yokose, Tomoyuki ; Kishida, Takeshi ; Miyagi, Yohei</creator><creatorcontrib>Okubo, Yoichiro ; Yamamoto, Yayoi ; Sato, Shinya ; Yoshioka, Emi ; Suzuki, Masaki ; Washimi, Kota ; Osaka, Kimito ; Suzuki, Takahisa ; Yokose, Tomoyuki ; Kishida, Takeshi ; Miyagi, Yohei</creatorcontrib><description>In prostate cancer, accurate diagnosis and grade group (GG) decision based on biopsy findings are essential for determining treatment strategies. Diagnosis by experienced urological pathologists is recommended; however, their contribution to patient benefits remains unknown. Therefore, we analyzed clinicopathological information to determine the significance of reassessment by experienced urological pathologists at a high-volume institution to identify factors involved in the agreement or disagreement of biopsy and surgical GGs. In total, 1325 prostate adenocarcinomas were analyzed, and the GG was changed in 452/1325 (34.1%) cases (359 cases were upgraded, and 93 cases were downgraded). We compared the highest GG based on biopsy specimens, with the final GG based on surgical specimens of 210 cases. The agreement rate between the surgical GG performed and assessed in our institute and the highest biopsy GG assessed by an outside pathologist was 34.8% (73/210); the agreement rate increased significantly to 50% (105/210) when biopsy specimens were reevaluated in our institute (chi-square test, P  &lt; 0.01). Multivariate logistic regression analysis showed that only the length of the lesion in the positive core with the highest GG in the biopsy was a significant factor for determining the agreement between biopsy GG and surgical GG, with an odds ratio of 1.136 (95% confidence interval: 1.057–1.221; P  &lt; 0.01). Thus, reassessment by experienced urological pathologists at high-volume institutions improved the agreement rate. However, it should be noted there is a high probability of discordance between a small number of lesions or short lesions and surgical GG.</description><identifier>ISSN: 0945-6317</identifier><identifier>EISSN: 1432-2307</identifier><identifier>DOI: 10.1007/s00428-022-03272-0</identifier><identifier>PMID: 35015130</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Agreements ; Biopsy ; Chi-square test ; Confidence intervals ; Diagnosis ; Discordance ; Humans ; Lesions ; Male ; Medical diagnosis ; Medicine ; Medicine &amp; Public Health ; Neoplasm Grading ; Original ; Original Article ; Pathologists ; Pathology ; Prostate ; Prostate - pathology ; Prostate cancer ; Prostatectomy ; Prostatic Neoplasms - pathology ; Regression analysis ; Statistical analysis ; Statistical tests</subject><ispartof>Virchows Archiv : an international journal of pathology, 2022-05, Vol.480 (5), p.979-987</ispartof><rights>The Author(s) 2022</rights><rights>2022. The Author(s).</rights><rights>The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c540t-d5f6256c5fe1cd5acd9c29cd2f39f5a12676da802b30af11f4c115563c60fab63</citedby><cites>FETCH-LOGICAL-c540t-d5f6256c5fe1cd5acd9c29cd2f39f5a12676da802b30af11f4c115563c60fab63</cites><orcidid>0000-0002-7079-4454</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00428-022-03272-0$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00428-022-03272-0$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35015130$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Okubo, Yoichiro</creatorcontrib><creatorcontrib>Yamamoto, Yayoi</creatorcontrib><creatorcontrib>Sato, Shinya</creatorcontrib><creatorcontrib>Yoshioka, Emi</creatorcontrib><creatorcontrib>Suzuki, Masaki</creatorcontrib><creatorcontrib>Washimi, Kota</creatorcontrib><creatorcontrib>Osaka, Kimito</creatorcontrib><creatorcontrib>Suzuki, Takahisa</creatorcontrib><creatorcontrib>Yokose, Tomoyuki</creatorcontrib><creatorcontrib>Kishida, Takeshi</creatorcontrib><creatorcontrib>Miyagi, Yohei</creatorcontrib><title>Diagnostic significance of reassessment of prostate biopsy specimens by experienced urological pathologists at a high-volume institution</title><title>Virchows Archiv : an international journal of pathology</title><addtitle>Virchows Arch</addtitle><addtitle>Virchows Arch</addtitle><description>In prostate cancer, accurate diagnosis and grade group (GG) decision based on biopsy findings are essential for determining treatment strategies. Diagnosis by experienced urological pathologists is recommended; however, their contribution to patient benefits remains unknown. Therefore, we analyzed clinicopathological information to determine the significance of reassessment by experienced urological pathologists at a high-volume institution to identify factors involved in the agreement or disagreement of biopsy and surgical GGs. In total, 1325 prostate adenocarcinomas were analyzed, and the GG was changed in 452/1325 (34.1%) cases (359 cases were upgraded, and 93 cases were downgraded). We compared the highest GG based on biopsy specimens, with the final GG based on surgical specimens of 210 cases. The agreement rate between the surgical GG performed and assessed in our institute and the highest biopsy GG assessed by an outside pathologist was 34.8% (73/210); the agreement rate increased significantly to 50% (105/210) when biopsy specimens were reevaluated in our institute (chi-square test, P  &lt; 0.01). Multivariate logistic regression analysis showed that only the length of the lesion in the positive core with the highest GG in the biopsy was a significant factor for determining the agreement between biopsy GG and surgical GG, with an odds ratio of 1.136 (95% confidence interval: 1.057–1.221; P  &lt; 0.01). Thus, reassessment by experienced urological pathologists at high-volume institutions improved the agreement rate. However, it should be noted there is a high probability of discordance between a small number of lesions or short lesions and surgical GG.</description><subject>Agreements</subject><subject>Biopsy</subject><subject>Chi-square test</subject><subject>Confidence intervals</subject><subject>Diagnosis</subject><subject>Discordance</subject><subject>Humans</subject><subject>Lesions</subject><subject>Male</subject><subject>Medical diagnosis</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Neoplasm Grading</subject><subject>Original</subject><subject>Original Article</subject><subject>Pathologists</subject><subject>Pathology</subject><subject>Prostate</subject><subject>Prostate - pathology</subject><subject>Prostate cancer</subject><subject>Prostatectomy</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Regression analysis</subject><subject>Statistical analysis</subject><subject>Statistical tests</subject><issn>0945-6317</issn><issn>1432-2307</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kc2OFCEUhYnROO3oC7gwJG7clHKhoLo2Jmb8TSZxo2tCUVDNpBpKLjWx38DHlp4ex5-FG8jN-e65XA4hT4G9BMa6V8hYy7cN47xhgnf1vEc20ArecMG6-2TD-lY2SkB3Rh4hXjHGYQvqITkTkoEEwTbkx9tgppiwBEsxTDH4YE20jiZPszOIDnHvYjnWS66cKY4OIS14oLg4G6qIdDhQ931xObjaOtI1pzlN1Wimiym7mwILUlOoobsw7ZrrNK97R0Osg8taQoqPyQNvZnRPbu9z8vX9uy8XH5vLzx8-Xby5bKxsWWlG6RWXykrvwI7S2LG3vLcj96L30gBXnRrNlvFBMOMBfGsBpFTCKubNoMQ5eX3yXdZh70Zbd8tm1ksOe5MPOpmg_1Zi2OkpXeueCdEBVIMXtwY5fVsdFr0PaN08m-jSipor2PYg-1ZU9Pk_6FVac6zrVUqKFoRSrFL8RNn6v5idv3sMMH0MWp-C1jVofRO0PjY9-3ONu5ZfyVZAnACsUpxc_j37P7Y_AaVFuFs</recordid><startdate>20220501</startdate><enddate>20220501</enddate><creator>Okubo, Yoichiro</creator><creator>Yamamoto, Yayoi</creator><creator>Sato, Shinya</creator><creator>Yoshioka, Emi</creator><creator>Suzuki, Masaki</creator><creator>Washimi, Kota</creator><creator>Osaka, Kimito</creator><creator>Suzuki, Takahisa</creator><creator>Yokose, Tomoyuki</creator><creator>Kishida, Takeshi</creator><creator>Miyagi, Yohei</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7079-4454</orcidid></search><sort><creationdate>20220501</creationdate><title>Diagnostic significance of reassessment of prostate biopsy specimens by experienced urological pathologists at a high-volume institution</title><author>Okubo, Yoichiro ; Yamamoto, Yayoi ; Sato, Shinya ; Yoshioka, Emi ; Suzuki, Masaki ; Washimi, Kota ; Osaka, Kimito ; Suzuki, Takahisa ; Yokose, Tomoyuki ; Kishida, Takeshi ; Miyagi, Yohei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c540t-d5f6256c5fe1cd5acd9c29cd2f39f5a12676da802b30af11f4c115563c60fab63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Agreements</topic><topic>Biopsy</topic><topic>Chi-square test</topic><topic>Confidence intervals</topic><topic>Diagnosis</topic><topic>Discordance</topic><topic>Humans</topic><topic>Lesions</topic><topic>Male</topic><topic>Medical diagnosis</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Neoplasm Grading</topic><topic>Original</topic><topic>Original Article</topic><topic>Pathologists</topic><topic>Pathology</topic><topic>Prostate</topic><topic>Prostate - pathology</topic><topic>Prostate cancer</topic><topic>Prostatectomy</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Regression analysis</topic><topic>Statistical analysis</topic><topic>Statistical tests</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Okubo, Yoichiro</creatorcontrib><creatorcontrib>Yamamoto, Yayoi</creatorcontrib><creatorcontrib>Sato, Shinya</creatorcontrib><creatorcontrib>Yoshioka, Emi</creatorcontrib><creatorcontrib>Suzuki, Masaki</creatorcontrib><creatorcontrib>Washimi, Kota</creatorcontrib><creatorcontrib>Osaka, Kimito</creatorcontrib><creatorcontrib>Suzuki, Takahisa</creatorcontrib><creatorcontrib>Yokose, Tomoyuki</creatorcontrib><creatorcontrib>Kishida, Takeshi</creatorcontrib><creatorcontrib>Miyagi, Yohei</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Virchows Archiv : an international journal of pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Okubo, Yoichiro</au><au>Yamamoto, Yayoi</au><au>Sato, Shinya</au><au>Yoshioka, Emi</au><au>Suzuki, Masaki</au><au>Washimi, Kota</au><au>Osaka, Kimito</au><au>Suzuki, Takahisa</au><au>Yokose, Tomoyuki</au><au>Kishida, Takeshi</au><au>Miyagi, Yohei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnostic significance of reassessment of prostate biopsy specimens by experienced urological pathologists at a high-volume institution</atitle><jtitle>Virchows Archiv : an international journal of pathology</jtitle><stitle>Virchows Arch</stitle><addtitle>Virchows Arch</addtitle><date>2022-05-01</date><risdate>2022</risdate><volume>480</volume><issue>5</issue><spage>979</spage><epage>987</epage><pages>979-987</pages><issn>0945-6317</issn><eissn>1432-2307</eissn><abstract>In prostate cancer, accurate diagnosis and grade group (GG) decision based on biopsy findings are essential for determining treatment strategies. Diagnosis by experienced urological pathologists is recommended; however, their contribution to patient benefits remains unknown. Therefore, we analyzed clinicopathological information to determine the significance of reassessment by experienced urological pathologists at a high-volume institution to identify factors involved in the agreement or disagreement of biopsy and surgical GGs. In total, 1325 prostate adenocarcinomas were analyzed, and the GG was changed in 452/1325 (34.1%) cases (359 cases were upgraded, and 93 cases were downgraded). We compared the highest GG based on biopsy specimens, with the final GG based on surgical specimens of 210 cases. The agreement rate between the surgical GG performed and assessed in our institute and the highest biopsy GG assessed by an outside pathologist was 34.8% (73/210); the agreement rate increased significantly to 50% (105/210) when biopsy specimens were reevaluated in our institute (chi-square test, P  &lt; 0.01). Multivariate logistic regression analysis showed that only the length of the lesion in the positive core with the highest GG in the biopsy was a significant factor for determining the agreement between biopsy GG and surgical GG, with an odds ratio of 1.136 (95% confidence interval: 1.057–1.221; P  &lt; 0.01). Thus, reassessment by experienced urological pathologists at high-volume institutions improved the agreement rate. However, it should be noted there is a high probability of discordance between a small number of lesions or short lesions and surgical GG.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>35015130</pmid><doi>10.1007/s00428-022-03272-0</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-7079-4454</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0945-6317
ispartof Virchows Archiv : an international journal of pathology, 2022-05, Vol.480 (5), p.979-987
issn 0945-6317
1432-2307
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9033711
source MEDLINE; SpringerLink Journals
subjects Agreements
Biopsy
Chi-square test
Confidence intervals
Diagnosis
Discordance
Humans
Lesions
Male
Medical diagnosis
Medicine
Medicine & Public Health
Neoplasm Grading
Original
Original Article
Pathologists
Pathology
Prostate
Prostate - pathology
Prostate cancer
Prostatectomy
Prostatic Neoplasms - pathology
Regression analysis
Statistical analysis
Statistical tests
title Diagnostic significance of reassessment of prostate biopsy specimens by experienced urological pathologists at a high-volume institution
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T09%3A07%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnostic%20significance%20of%20reassessment%20of%20prostate%20biopsy%20specimens%20by%20experienced%20urological%20pathologists%20at%20a%20high-volume%20institution&rft.jtitle=Virchows%20Archiv%20:%20an%20international%20journal%20of%20pathology&rft.au=Okubo,%20Yoichiro&rft.date=2022-05-01&rft.volume=480&rft.issue=5&rft.spage=979&rft.epage=987&rft.pages=979-987&rft.issn=0945-6317&rft.eissn=1432-2307&rft_id=info:doi/10.1007/s00428-022-03272-0&rft_dat=%3Cproquest_pubme%3E2653413660%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2653413660&rft_id=info:pmid/35015130&rfr_iscdi=true